Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Myriad Genetics (MYGN) Minority Interest (2016 - 2021)

Myriad Genetics (MYGN) has disclosed Minority Interest for 5 consecutive years, with -$100000.0 as the latest value for Q3 2021.

  • On a quarterly basis, Minority Interest changed N/A to -$100000.0 in Q3 2021 year-over-year; TTM through Sep 2021 was -$100000.0, a N/A change, with the full-year FY2017 number at -$400000.0, changed N/A from a year prior.
  • Minority Interest was -$100000.0 for Q3 2021 at Myriad Genetics, roughly flat from -$100000.0 in the prior quarter.
  • In the past five years, Minority Interest ranged from a high of $100000.0 in Q1 2018 to a low of -$400000.0 in Q2 2017.
  • A 4-year average of -$133333.3 and a median of -$100000.0 in 2018 define the central range for Minority Interest.
  • Biggest YoY gain for Minority Interest was 200.0% in 2019; the steepest drop was 200.0% in 2019.
  • Myriad Genetics' Minority Interest stood at -$300000.0 in 2017, then soared by 66.67% to -$100000.0 in 2018, then surged by 200.0% to $100000.0 in 2019, then crashed by 200.0% to -$100000.0 in 2021.
  • Per Business Quant, the three most recent readings for MYGN's Minority Interest are -$100000.0 (Q3 2021), -$100000.0 (Q2 2021), and $100000.0 (Q4 2019).